Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group
  2. Taxonomy
  3. Term
  4. Other

Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer,

Go back to Resources

Meeting highlights: a reappraisal of research results for the local treatment of early stage breast cancer,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Normal behaviour of circulatory parameters during exercise. Reference values for heart rate and systemic blood pressure. The ECCIS Project data. Epidemiologia e Clinica della Cardiopatia Ischemica Silente],

Go back to Resources

Normal behaviour of circulatory parameters during exercise. Reference values for heart rate and systemic blood pressure. The ECCIS Project data. Epidemiologia e Clinica della Cardiopatia Ischemica Silente],

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Paclitaxel activity in heavily pre-treated breast cancer: A National Cancer Institute Treatment Referral Center trial,

Go back to Resources

Paclitaxel activity in heavily pre-treated breast cancer: A National Cancer Institute Treatment Referral Center trial,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Paclitaxel Activity in Heavily Pretreated Breast Cancer: A National Cancer Institute Treatment Referral Center Trial

Go back to Resources

Paclitaxel Activity in Heavily Pretreated Breast Cancer: A National Cancer Institute Treatment Referral Center Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Prostaglandin production by rat vaginal tissue, in vitro, in response to ethanol, a mild mucosal irritant,

Go back to Resources

Prostaglandin production by rat vaginal tissue, in vitro, in response to ethanol, a mild mucosal irritant,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Reliability of visual fields in AGIS,

Go back to Resources

Reliability of visual fields in AGIS,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Progress in HIV-1 vaccine development,

Go back to Resources

Progress in HIV-1 vaccine development,

Authors:

Location:

Go back to Resources

Evaluation of HIV-1 MN recombinant gp160 candidate vaccine,

Go back to Resources

Evaluation of HIV-1 MN recombinant gp160 candidate vaccine,

Authors:

Location:

Go back to Resources

Strategies for safety reporting in substance abuse trials.

Go back to Resources

Strategies for safety reporting in substance abuse trials.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Risk factors for rejection and infection in pediatric liver transplantation.

Go back to Resources

Risk factors for rejection and infection in pediatric liver transplantation.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Pagination

  • Previous page ‹‹
  • Page 98
  • Next page ››
Subscribe to Other
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification